Fentanyl Oral Prior Authorization (with Quantity Limit) Criteria – Medicare Part D
Prior Authorization Criteria for Approval
Fentanyl citrate lozenge (lollipop) will be approved when ALL of the following are met:
- ONE of the following:
- The patient has a documented diagnosis (i.e. medical records) of chronic cancer pain due to an active malignancy AND BOTH of the following:
- The prescriber has provided the patient’s type of cancer AND
- The patient is at least 16 years of age AND
- There is evidence of a claim that the patient is currently being treated with a longacting opioid with the requested medication OR
- The patient has a diagnosis that is supported in CMS approved compendia for the requested medication AND
- The patient has a documented diagnosis (i.e. medical records) of chronic cancer pain due to an active malignancy AND BOTH of the following:
- The patient will NOT be using the requested medication in combination with any other oral or nasal fentanyl medication AND
- ONE of the following:
- The requested quantity (dose) does NOT exceed the program quantity limit OR
- The requested quantity (dose) is greater than the program quantity limit AND BOTH of the following:
- Episodes of breakthrough pain cannot be controlled by modifying the long-acting opioid dosage AND
- The prescriber has provided information in support of therapy with a higher quantity (dose) for the requested indication
Length of Approval: 12 months
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2025 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.